A Clear Path to Successful AI Adoption in Medical Writing with Structured GenAI Pilots
AI has the potential to transform medical writing and regulatory processes in life sciences by accelerating document generation, ensuring consistency, and freeing up experts for higher-value work. Yet, many organizations struggle to realize this value in practice. Common pitfalls include unclear implementation roadmaps, investments in the wrong platforms, and solutions that don’t fit real-world workflows. From experience, this often results in lost momentum and wasted resources for Sponsors, CROs, and vendors alike.
We have found that a well-planned pilot program offers a smarter approach. In this interactive session, discover how a guided, results-driven pilot can help your team evaluate generative AI within your actual environment before making large-scale commitments. As an example, we will dive into how pilots of LINK AI pilot address critical success factors like system and workflow integrations, measurable productivity gains, and user acceptance.
Join us and learn how to build a business case rooted in concrete data, overcome skepticism, and set your organization on the path to scalable, successful AI adoption.
Details: May 29, 2025 at 11am ET
Who Should Attend:
- Medical writing, regulatory, and clinical documentation leaders
- Digital transformation, innovation, and IT leaders in pharma/CROs
- Clinical operations and study management teams interested in AI adoption
Key Takeaways:
- Gain guidance on building a robust business case with pilot performance metrics to secure leadership and cross-team support for AI implementation.
- Benchmark measurable productivity gains such as reduced draft timelines and faster summary creation, as demonstrated in the LINK AI Pilot.
- Review real-world pilot data showing improvements in document turnaround time, quality, and compliance.